By BARRY MEIER
Purdue Pharma tried to maximize profits by marketing the drug to keep patients on higher doses for longer periods, a lawsuit charges.
Published: January 30, 2019 at 07:00PM
from NYT Health https://nyti.ms/2TrbHQI
via IFTTT
from WordPress http://bit.ly/2Boa0wL
via IFTTT
No comments:
Post a Comment